Radar › Companies › Life Sciences · Delaware
Radar · Life Sciences in Delaware

Best Life Sciences Companies in Delaware, United States

The 139 best Life Sciences companies in Delaware, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Earendil.

139companies tracked
$2.7Bdisclosed funding
1unicorns
56have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × DELAWARE

Our analysis of 164 Life Sciences companies

$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
313kcombined LinkedIn audience
77%of audience held by top 3
3companies hiring publicly (12 mo)

Ranked: Best Life Sciences companies in Delaware

#CompanyDisclosed fundingLast roundEmployeesFounderTech stackWeb popularityPatents & IP focusRecent signals
1Earendil
Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics
45Funding top 12%AI top 35%Talent top 38%Patents top 46%
All 8 signals ▾
Fundingtop 12%
AItop 35%
Talenttop 38%
Patentstop 46%
Innovationtop 50%
Globaltop 50%
Techbottom 36%
Marketbottom 25%
Funding: Raised $787M across 1 rounds · 1 rounds over 1 yrs (1.0/yr)
AI: Product described with: ai-driven, deep learning
rank vs industry peers · Fliar Intelligence Index 45/100
$787M3 mo ago—Zhenping Zhu
Co-Founder & Co-CEO
GoDaddy Website BuilderReactRequireJS+8Top 50M6 patents
Therapeutic antibodies, especially bispecific and anti‑TL1A biologics for immune modulation
—
2Incyte
Developer of small molecules for the treatment of different cancer and skin diseases
$750M151 mo ago1,387Herve Hoppenot
Chairman and CEO
DrupalApple iCloud MailPHP+22Top 5M7,097 patents
Small-molecule kinase inhibitors and formulations for JAK/TYK, PI3K, and related therapies
2 awards
3NiKang Therapeutics
Developer of therapeutics for the treatment of cancer
$260M60 mo ago24Zhenhai Gao
Co-Founder & CEO
——203 patents
Design of heterocyclic small‑molecule inhibitors for oncology targets (HIF‑2α, KRAS G12D, CDK2, SH2).
—
44G Clinical
Randomization and Trial Supply Management (RTSM) solutions for clinical trials
$259M59 mo ago201
201 → 402 (+100%)
—HubSpot CMS HubBootstrapAmazon Web Services+21Top 10M23 patents
Clinical trial supply forecasting and randomization validation software for trial management systems
1 job opening
5Zoe
Provider of gut health testing services and plant based supplements
$118M13 mo ago109George Hadjigeorgiou
Co-Founder
DatoCMSSentryNode.js+15Top 500k—1 launch
6Sepax Technologies
Products and services for biomolecular separation
$109M55 mo ago57
57 → 88 (+54%)
Sean Huang
CEO
Cart FunctionalityDreamWeaverSalesforce+12Top 5M2 patents
Patents concentrated in chemistry & materials
—
7Novel Therapeutic Technologies
Topical drug delivery technology
$75M174 mo ago—Zacki Turkeltaub
President & CEO
————
8NRx 🦄
Developer of therapeutics for COVID-19 and neurological disorders
$55M52 mo ago22Daniel Javitt
Co-Founder
WordPress Block EditorElementorWordPress+27Top 10M——
9Ayala Pharma
Developer of small molecule-based therapeutics for cancer treatment
$51M64 mo ago21—————
10Converge
Developer of GenAI computational tools for drug discovery and manufacturing
$30M8 mo ago—Dov Gertz
Co-Founder & CEO
Framer SitesApple iCloud MailGoogle Workspace+21Top 10M——
11B&W Tek
Manuafacturer of optical spectroscopy, laser instrumentation and portable lab systems
$20M128 mo ago56
56 → 53 (-5%)
—WordPressMySQLPHP+14Top 10M60 patents
Patents concentrated in construction
2 awards
12iBio
Developer of biologics products by using transient gene expression
$18M13 mo ago23
23 → 57 (+148%)
—WordPressMySQLPHP+25Top 10M135 patents
Therapeutic antibody engineering with conditional activation and masked antibody technologies
—
13dermaliq Therapeutics
Developer of therapeutics for dermatological indicatications
$15M53 mo ago4Oliver Schluter
Co-Founder & CFO
————
14Uvax Bio
Developer of therapeutic vaccines to treat viral infections
$11M69 mo ago16Jiang Zhu
Co-Founder and Interim Chief Scientific Officer
————
15DE3PBIO
Developer of active functional ingredients for food, nutraceutical, beauty applications
$9M34 mo ago—Priyanka Srinivas
Co-Founder & Director & Chief Of Org Dev & Sales Officer
WordPressMySQLPHP+17Top 50M—1 award
16CuraVac
Biotech pioneering targeted active immunotherapies for autoimmune diseases, aiming for long-term immunity
$8M—6———17 patents
Peptide-based therapeutic vaccines targeting autoimmune myasthenia gravis
—
17Leucine
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory
$8M32 mo ago41Vivek Gera
Co-Founder & CEO
WebflowGSAPStripe+21Top 5M——
18Inteliquet
Provider of market research and consulting services for pharmaceutical companies
$7M141 mo ago28Jean Roberson
CFO
——6 patents
Automated metadata extraction and classification code parsing for software tools
—
19CD Diagnostics
Immunoassay solutions for joint pain diagnosis and infection detection
$7M145 mo ago56———94 patents
Cooperative primer technologies for nucleic acid amplification, genotyping, and infection detection
—
20RxWare
Provider of solutions for managing manufacturing operations in manufacturing industries
$7M10 mo ago30—————
21CorriXR Therapeutics
Developer of gene-based therapies for cancer treatment
$7M10 mo ago6Eric Kmiec
CEO
———1 award
22Carecubes
Provider of mobile isolation units for infection control in hospitals
$6M3 mo ago4Saul Griffith
Co-Founder
WordPressMySQLPHP+28Top 50M9 patents
Infection-control isolation rooms and units for medical facilities
—
23Virion Therapeutics
Developing T cell immunotherapies for cancer and chronic infectious diseases
$5M60 mo ago7Hildegund Ertl
Scientific founder
WordPressSkolengoMySQL+24Top 50M—1 launch
24CureDM
Developing new therapies based on HIP for diabetes
$5M202 mo ago3———64 patents
Therapeutic peptides for pancreatic islet regeneration and diabetes treatment
—
25Treventis
Small molecule therapeutics targeting misfolded proteins in CNS diseases
$4M36 mo ago15Christopher Barden
Co-Founder & CEO
WordPressMySQLPHP+20Top 50M72 patents
Therapeutics for neurodegenerative diseases targeting amyloid aggregation and butyrylcholinesterase inhibition.
—
26Sensible Biotechnologies
Developer of mRNA technology for therapeutics and vaccines
$4M39 mo ago12Miroslav Gasparek
Co-Founder & CEO
WebflowApple iCloud MailGoogle Workspace+11Top 50M——
27Electronic Lab Logs
Provider of cloud-based electronic laboratory log management platform
$4M23 mo ago6Daniel Summers
Founder & CEO
TypeScriptChart.jsBootstrap+19Top 50M——
28NucsAI
AI-powered healthcare platform for advanced analysis of tumor lesions
$4M22 mo ago—Nijat Ahmadov
Co-Founder & CEO
WebflowRecruiteejsDelivr+9Top 50M——
29GOLO
Provider of dietary supplements for weight loss
$3M124 mo ago61
61 → 64 (+5%)
Chris Lundin
CEO
Cart FunctionalityShopifySentry+43Top 500k14 patents
Patents concentrated in health & consumer products
—
30Amino
Developer of clinically tested essential amino acid blends for health and performance
$3M33 mo ago—Robert Wolfe
Co-Founder
Cart FunctionalityShopifySentry+38Top 5M34 patents
Therapeutic nutritional supplements for liver metabolism and muscle health; AI-driven healthcare data analytics.
—
31logicflo.ai
Provider of an AI agent workforce tailored for life sciences companies
$3M11 mo ago—Arun Ramakrishnan
Co-Founder
———2 job openings
32NuCalm
Neuroscience-backed app for stress relief, sleep, focus, and recovery
$2M102 mo ago12—Cart FunctionalityShopifyZURB Foundation+30Top 5M——
33Notitia
Developer of therapeutic solutions for the treatment of diabetes & infectious diseases
$2M66 mo ago—Liping Zhao
Co-Founder
————
34Plexiform Biosciences
Developer of therapeutics for retinal disorders to improve vision clarity
$1M18 mo ago—Edward Yavitz
Co-Founder & CMO
————
35AbeXXa Biologics
Life science research tools: antibodies, proteins, ELISA kits, and related reagents
$1M117 mo ago5Debra Weidanz
Co-Founder & CEO
——27 patents
Immuno‑oncology antibodies targeting non‑classical HLA‑I/neoantigen complexes for cancer therapy
—
36Halo Columns
Developer of high-performance liquid chromatography columns for researchers
$873K35 mo ago46—Cart FunctionalityWooCommerceWordPress+32Top 5M——
37Von Vascular
Developer of medical devices for thrombectomy procedures
$693K14 mo ago—Manning Hanser
CEO
————
38Cellergy Pharma
Developer of immunotherapeutics to treat allergic diseases
$600K16 mo ago—Mark Ma
Co-Founder
————
39BioCurie
AI-based software for cell and gene therapy
$500K12 mo ago—Irene Rombel
Co-Founder & CEO
——7 patents
AI‑enabled data‑driven development and manufacturing of biopharmaceutical processes
—
40Evidose
Platform providing high-quality and scientifically robust data for the supplement and pharma industries
$500K30 mo ago—Anna Litwinska
Co-Founder & CEO
————
41Microbial Identification
Chromatography solutions for microbiology and forensics, including software and testing services
$347K93 mo ago20—————
42Mogling Bio
Developer of cell-based therapeutics for blood cancer
$300K20 mo ago—Hartmut Geiger
Co-Founder
————
43PROTEINEA
Developer of AI-driven protein engineering platform for antibody-based therapeutic discovery
$250K63 mo ago43Abdulaziz Elgammal
Co-founder & CPO
WebflowGSAPcore-js+11Top 10M16 patents
Optimizing gene and codon sequences for efficient recombinant protein expression
—
44Microgenesis
Provider of smart solutions for fertility & pregnancyhealth monitoring
$250K72 mo ago15Gabriela Gutierrez
Founder
Wix eCommerceWixSentry+20Top 10M14 patents
Diagnostic and therapeutic assessment of reproductive inflammatory conditions for fertility
—
45Intact Therapeutics
Developer of localised drug delivery systems
$150K36 mo ago4Sid Sinha
Founder
————
46Toolchest
Provider of an API for data analytics
$125K46 mo ago3Bryce Cai
Co-Founder & CTO
————
47Targagenix
Developer of novel compounds intended to treat drug-resistant tumors and cancer stem cells
$100K93 mo ago8———20 patents
Nanoemulsion-based taxoid drug delivery systems combined with cancer immunotherapy
—

Top 12 Life Sciences companies in Delaware

#1
Series D · Middletown, Delaware · founded 2021
$787Mraised
▾

Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics. It transform the discovery of protein therapeutics using deep learning and high-throughput biology. The company aims to deliver transformative medicines to patients worldwide through its innovative approaches.

Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 12%
AI
top 35%
Talent
top 38%
Patents
top 46%
Innovation
top 50%
Global
top 50%
Funding: Raised $787M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series D (Mar 2026)
AI: Product described with: ai-driven, deep learning
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding rounds
  • Mar 2026Series D$787M
Founders & team
Zhenping ZhuCo-Founder & Co-CEOJian PengFounder & Co-CEO
Investors
Dimension, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi Ventures
#2
Late Stage · New Castle, Delaware · founded 2017 · 109 employees
$118Mraised
▾

Provider of gut health testing services and plant based supplements. Analysis of biological samples provides information regarding the composition of the gut microbiome. Dietary recommendations are generated based on individual test results to influence nutritional choices. The business also distributes fiber and nutrient dense food additives designed to support digestive function and metabolic health.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 76k LinkedIn followers — 24.1% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Apr 2025Unattributed$45.9K
  • Oct 2024Unattributed$162.7K
  • Mar 2024Unattributed$19.7M
  • Dec 2023Unattributed$2.6M
Founders & team
George HadjigeorgiouCo-FounderTim SpectorCo-Founder
Investors
Coefficient Capital, DART Ventures, Ahren, Accomplice, Transformational Healthcare Venture Capital, Daphni
Tech stack
CloudflareDatocmsGoogle Tag ManagerGoogle WorkspaceHstsMicrosoft Advertising
#3
Series A · Wilmington, Delaware · founded 2014 · 4 employees
$6.5Mraised
▾

Provider of mobile isolation units for infection control in hospitals. It offers medical-grade isolation technology-based negative-pressure isolation unit which has two lean-in glove walls, hugsuit, and others. It allow care givers to isolate patients and prevent the spread of infectious diseases.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 505 LinkedIn followers
Funding rounds
  • Mar 2026Series A$6.5M
Founders & team
Saul GriffithCo-FounderPatti LordCo-FounderAlex LaskeyCo-Founder & CEO
Investors
Schooner Capital, Lifeforce Capital, CQuence Health Group
Tech stack
BluehostCdnjsCloudflareCloudflare Bot ManagementCore-JsEndurance Page Cache
#4
Series A · Wilmington, Delaware · founded 2024
$30.5Mraised
▾

Developer of GenAI computational tools for drug discovery and manufacturing. The company offers a bio-LLM library with foundation models across biological languages. These models are enhanced with curated data and fine-tuned on task-specific datasets. The platform is deployed through an application layer focused on prediction, explainability, and generation. It provides AI-driven antibody discovery and optimization, protein yield maximization, and cellular response prediction. The platform ensures data privacy and security, offering complete control and fully managed infrastructure.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Funding rounds
  • Sep 2025Series A$25M
  • Nov 2024Seed$5.5M
Founders & team
Dov GertzCo-Founder & CEO Oded KalevCo Founder & CTO
Investors
TLV Partners, Bessemer Venture Partners, Vintage Investment Partners, Saras Capital
Tech stack
Amazon Web ServicesApple Icloud MailCdnjsCloudflareCloudflare Bot ManagementComeet
#5
Public · Wilmington, Delaware · founded 2008 · 23 employees
$18.5Mraised
▾

Developer of biologics products by using transient gene expression. It develops and offers product applications of its iBioLaunch and iBioModulator platforms for proprietary and biosimilar products. The iBioLaunch platform is a proprietary technology for the development and production of biologics using transient gene expression in unmodified green plants. The offering applies to biologics, including monoclonal antibodies, other therapeutic proteins, and vaccines, optionally robotic, multi-product manufacturing facilities.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 13k LinkedIn followers — 4.0% of this cohort's audience
Funding rounds
  • Apr 2025Post IPO$6.2M
  • Mar 2020Post IPO—
  • Feb 2016Post IPO$2.2M
  • Nov 2010Post IPO$7.1M
Investors
Lincoln Park Capital
Tech stack
Apache Http ServerBootstrapBugherdBunnyCdnjsCloudflare
#6
Series A · Newark, Delaware · founded 2022 · 6 employees
$6.5Mraised
▾

Developer of gene-based therapies for cancer treatment. It offers a CRISPR/Cas molecule based on gene editing that disables the genome of a tumor cell and targets the NRF2 gene for the treatment of solid tumors.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
  • Aug 2025Series A$1M
  • Jan 2024Seed—
  • Oct 2023Seed—
  • Jun 2022Seed$6.5M
Founders & team
Eric KmiecCEO
Investors
Cortado Ventures, Delaware Office of Work-based Learning, Delaware
#7
Series A · Wilmington, Delaware · founded 2013 · 30 employees
$6.5Mraised
▾

Provider of solutions for managing manufacturing operations in manufacturing industries

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
  • Aug 2025Series A$6.1M
  • Oct 2019Series A$6M
  • Dec 2017Seed—
  • Jul 2014Seed$550K
Investors
Windham Venture Partners, PharMedQuest, IQVIA, Windham Capital Partners, StartUp Health, Vodia Capital
#8
Seed · Dover, Delaware · founded 2024
$2.7Mraised
▾

Provider of an AI agent workforce tailored for life sciences companies. The platform offers pre-built AI agents for workflows such as MSL decks, internal training materials, congress posters, CME content, journal articles, MI response packages, and MLR-ready content. It integrates with tools like Veeva and PubMed to synthesize MSL notes with clinical studies, cutting research time from weeks to hours while ensuring scientifically consistent, cited outputs.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: expert evaluation panel member, Marketing Associate
Funding rounds
  • Jun 2025Seed$2.7M
Founders & team
Arun RamakrishnanCo-FounderUdith VaidyanathanCo-Founder & CEO
Investors
Lightspeed
#9
Seed · Dover, Delaware · founded 2025
$23Kraised
▾

AI platform focused on accelerating protein engineering and drug discovery workflows. It provides accessible tools for researchers to predict, visualize, and analyze protein structures using advanced models like AlphaFold2 and ESM3.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 366 LinkedIn followers
Activity: 1 product launches announced in 12 mo
Funding rounds
  • May 2026Seed—
  • May 2026Grant (prize money)$23K
Founders & team
Anindyadeep SannigrahiCo-FounderCory KornowiczCo-Founder
Investors
3F VC, Mercatus
#10
Series C · Dover, Delaware · founded 2015 · 201 employees
$259.3Mraised
▾

Randomization and Trial Supply Management (RTSM) solutions for clinical trials. RTSM systems support the randomization of patients into different arms of a trial and the supply of study drugs to sites. It claims that its solution uses natural language specification which directly programs the system.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers — 3.9% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Senior Growth Marketing Manager
Funding rounds
  • Jun 2021Series C$230M
  • Jan 2020Series B$14.6M
  • Feb 2019Series B$7.2M
  • Oct 2016Series A$5M
Investors
Schooner Capital, Goldman Sachs Investment Partners, Western Technology Investment, Migration Capital, First Analysis
Tech stack
Amazon SesAmazon Web ServicesBootstrapBugherdCdnjsCloudflare
#11
Seed · Wilmington, Delaware · founded 2013 · 6 employees
$3.9Mraised
▾

Provider of cloud-based electronic laboratory log management platform. The company has developed a lab records and tasks maintenance software that allows users to report, and track records. The system has features for tracking tasks of different research instruments, get real-time data, and more.

Funding rounds
  • Jul 2024Seed$1.8M
  • Mar 2024Seed$1.8M
  • Oct 2021Seed$326.6K
Founders & team
Daniel SummersFounder & CEO
Investors
VentureSouth
Tech stack
WordpressMysqlPhpFlywheel
#12
Seed · Wilmington, Delaware · founded 2021
$500Kraised
▾

AI-based software for cell and gene therapy. The company is pioneering mechanistic AI to revolutionize cell and gene therapy manufacturing to make life saving therapies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 960 LinkedIn followers
Funding rounds
  • Jun 2025Seed$500K
Founders & team
Irene RombelCo-Founder & CEORichard BraatzCo-Founder

Funding & investor landscape

$2.7Btotal disclosed funding
50companies funded
112disclosed rounds
1rounds last 90 days
Most active investors
HHS8 rounds
Delaware3 rounds
Y Combinator3 rounds
BioAdvance2 rounds
CBC Group2 rounds
First Analysis2 rounds
IQVIA2 rounds
IndieBio2 rounds
Mid Atlantic Bio Angels2 rounds
Orbimed2 rounds

Notable founders

Zhenping Zhu
Co-Founder & Co-CEO · Earendil
Jian Peng
Founder & Co-CEO · Earendil
George Hadjigeorgiou
Co-Founder · Zoe
Tim Spector
Co-Founder · Zoe
Saul Griffith
Co-Founder · Carecubes
Patti Lord
Co-Founder · Carecubes
Dov Gertz
Co-Founder & CEO · Converge
Oded Kalev
Co Founder & CTO · Converge
Eric Kmiec
CEO · CorriXR Therapeutics
Arun Ramakrishnan
Co-Founder · logicflo.ai
Udith Vaidyanathan
Co-Founder & CEO · logicflo.ai
Anindyadeep Sannigrahi
Co-Founder · LiteFold
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH FROM Delaware · institutions

What Delaware researches in biotechnology

University of Delaware and Delaware State University lead Delaware's biotechnology research, focusing optimistically on protein purification, antibody development, and infectious disease, with recent output surging sharply post-2020.

27 papersstance +0.3433% breakthrough22% concern
breakthrough · advancement · concern
local research themes
Protein purification and stabilityMonoclonal and Polyclonal Antibodies ResearchViral Infectious Diseases and Gene Expression in InsectsHelminth infection and controlVirus-based gene therapy researchNuclear Structure and Function
top institutions
  • University of Delaware22
  • Delaware State University5

Common questions

How many Life Sciences companies are there in Delaware, United States?
Radar tracks 139 indexable Life Sciences companies headquartered in Delaware, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Delaware, United States?
The Life Sciences companies in Delaware, United States on this list have raised a combined $2.7B in disclosed equity funding across 50 funded companies.
Which is the highest-funded Life Sciences company in Delaware, United States?
Earendil is the highest-funded Life Sciences company in Delaware, United States, with $787M in disclosed equity funding.
How many Life Sciences companies in Delaware, United States are funded?
50 of the 139 Life Sciences companies in Delaware, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Delaware, United States?
1 Life Sciences company in Delaware, United States on this list is valued at $1B or more.
Who are the top investors in Delaware, United States Life Sciences companies?
The most active investors in Delaware, United States Life Sciences companies on this list include HHS, Delaware, Y Combinator, BioAdvance, CBC Group.
Riya SenguptaFinancials

Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.

Coming soon